Evidence map›Paper›PMID 34997577›Full record

ArticleEpilepsia2022

Intracranial electroencephalographic biomarker predicts effective responsive neurostimulation for epilepsy prior to treatment.

Brittany H Scheid, John M Bernabei, Ankit N Khambhati, Sofia Mouchtaris, Jay Jeschke, Dani S Bassett, Danielle Becker, Kathryn A Davis, Timothy Lucas, Werner Doyle and 4 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Epilepsia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. A guide to neuromodulation in drug-resistant epilepsy.Epileptic disorders : international epilepsy journal with videotape · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Therapeutic approaches targeting seizure networks.Frontiers in network physiology · 2024
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Brittany H ScheidDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-8528-0085
John M BernabeiDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-3012-1263
Ankit N KhambhatiDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0001-6182-4677
Sofia MouchtarisDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jay JeschkeComprehensive Epilepsy Center, NYU Langone Health, New York, New York, USA.
Dani S BassettDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-6183-4493
Danielle BeckerCenter for Neuroengineering and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-4792-8055
Kathryn A DavisDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Timothy LucasCenter for Neuroengineering and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Werner DoyleDepartment of Neurosurgery, NYU Langone, New York, New York, USA.
Edward F ChangDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
Daniel FriedmanComprehensive Epilepsy Center, NYU Langone Health, New York, New York, USA.ORCID 0000-0003-1068-1797
Vikram R RaoDepartment of Neurology, University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0002-6389-2638
Brian LittDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-2732-6927
University of Pennsylvania · USHospital of the University of Pennsylvania · USUniversity of California, San Francisco · USNYU Langone Health · USUniversity of the Sciences · US

Funding

Ghost in the Machine: Melding Brain, Computer and BehaviorDP1NS122038 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI LITT, BRIAN · 2020 to 2024
$5.7M
Training Program in Neuroengineering and MedicineT32NS091006 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Brian Litt · 2015 to 2026
$4.1M
Optimized Intracranial EEG Targeting in Focal Epilepsy based upon Neuroimaging ConnectomicsR01NS116504 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI DAVIS, KATHRYN ADAMIAK · 2021 to 2025
$3.3M
Virtual Resection to Treat EpilepsyR01NS099348 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI BASSETT, DANIELLE SMITH, LITT, BRIAN · 2016 to 2019
$2.3M
Virtual Resection to Treat EpilepsyR56NS099348 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI BASSETT, DANIELLE SMITH, LITT, BRIAN · 2021 to 2021
$552k
NINDS NIH HHS DP1 NS122038NINDS NIH HHS R01 NS099348NINDS NIH HHS R01 NS116504NINDS NIH HHS R56 NS099348NINDS NIH HHS T32 NS091006
6 · The paper itself

Abstract

objectiveDespite the overall success of responsive neurostimulation (RNS) therapy for drug-resistant focal epilepsy, clinical outcomes in individuals vary significantly and are hard to predict. Biomarkers that indicate the clinical efficacy of RNS-ideally before device implantation-are critically needed, but challenges include the intrinsic heterogeneity of the RNS patient population and variability in clinical management across epilepsy centers. The aim of this study is to use a multicenter dataset to evaluate a candidate biomarker from intracranial electroencephalographic (iEEG) recordings that predicts clinical outcome with subsequent RNS therapy.

methodsWe assembled a federated dataset of iEEG recordings, collected prior to RNS implantation, from a retrospective cohort of 30 patients across three major epilepsy centers. Using ictal iEEG recordings, each center independently calculated network synchronizability, a candidate biomarker indicating the susceptibility of epileptic brain networks to RNS therapy.

resultsIctal measures of synchronizability in the high-γ band (95-105 Hz) significantly distinguish between good and poor RNS responders after at least 3 years of therapy under the current RNS therapy guidelines (area under the curve = .83). Additionally, ictal high-γ synchronizability is inversely associated with the degree of therapeutic response. SIGNIFICANCE: This study provides a proof-of-concept roadmap for collaborative biomarker evaluation in federated data, where practical considerations impede full data sharing across centers. Our results suggest that network synchronizability can help predict therapeutic response to RNS therapy. With further validation, this biomarker could facilitate patient selection and help avert a costly, invasive intervention in patients who are unlikely to benefit.

Indexed as

Drug Resistant EpilepsyEpilepsyBiomarkersElectrocorticographyHumansRetrospective StudiesBiomarkersfunctional connectivitymulticenternetwork neuroscienceneuromodulationsynchronizability

Identifiers

PMID34997577
PMCPMC9887634
OpenAlexW4205461504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.